4.6 Article

Association of serum neurofilament light with microglial activation in multiple sclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Clinical Neurology

Serum Glial Fibrillary Acidic Protein Compared With Neurofilament Light Chain as a Biomarker for Disease Progression in Multiple Sclerosis

Stephanie Meier et al.

Summary: This study found that serum glial fibrillary acidic protein (sGFAP) and serum neurofilament light chain (sNfL) are correlated with features of disease progression in multiple sclerosis (MS) and can predict disease progression. sGFAP may serve as a useful biomarker for disease progression in MS in individual patient management and drug development.

JAMA NEUROLOGY (2023)

Review Clinical Neurology

Serum neurofilament light in MS: The first true blood-based biomarker?

Simon Thebault et al.

Summary: This review highlights the potential role of serum neurofilament light chain (sNfL) as a promising blood-derived biomarker in the routine management of multiple sclerosis (MS) patients. Various studies have shown associations of sNfL levels with outcomes of interest, including inflammatory activity, progression, treatment response, and prediction/prognosis, supporting its potential as an objective, convenient, and cost-effective adjunct to clinical assessment. Future research is needed to further explore the limitations of sNfL and pave the way for other promising biomarkers for precision medicine in MS patients.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Clinical Neurology

CSF chitinase 3-like 1 is associated with iron rims in patients with a first demyelinating event

Manuel Comabella et al.

Summary: The presence of iron rims in patients with a first demyelinating event is associated with higher T2 lesion volume, a higher number of gadolinium-enhancing lesions, and increased levels of CSF CHI3L1 and serum NfL.

MULTIPLE SCLEROSIS JOURNAL (2022)

Article Clinical Neurology

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

Pascal Benkert et al.

Summary: sNfL is a biomarker of neuronal damage used in monitoring disease activity in multiple sclerosis patients. This study established a reference database to correct for age and BMI, showing sNfL's potential in identifying individuals at risk for future disease activity. The results suggest that sNfL Z scores could predict acute and chronic disease activity in multiple sclerosis patients, with higher Z scores indicating increased risk.

LANCET NEUROLOGY (2022)

Article Clinical Neurology

Blood Neurofilament Light in Progressive Multiple Sclerosis Post Hoc Analysis of 2 Randomized Controlled Trials

David Leppert et al.

Summary: Elevated baseline plasma neurofilament light (pNfL) levels were associated with higher risks of future disability progression and brain atrophy, regardless of acute disease activity in patients with progressive multiple sclerosis. Treatment with siponimod or fingolimod reduced pNfL levels and may serve as a meaningful outcome measure in studies of progressive multiple sclerosis.

NEUROLOGY (2022)

Article Clinical Neurology

Neurofilament Light Chain Levels in Multiple Sclerosis Correlate With Lesions Containing Foamy Macrophages and With Acute Axonal Damage

Aletta van den Bosch et al.

Summary: This study aimed to investigate the association between white matter lesion activity, acute axonal damage, and axonal density in MS with CSF neurofilament light chain (NfL) levels. The results showed that active and mixed white matter MS lesions with foamy microglia exhibited high acute axonal damage and correlated with elevated CSF NfL levels. These findings support the use of CSF NfL as a biomarker to monitor inflammatory demyelinating lesion activity with axonal damage in MS.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2022)

Article Radiology, Nuclear Medicine & Medical Imaging

Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study

Milena Sales Pitombeira et al.

Summary: This study used PET imaging to investigate the characteristics of microglia activation and myelin injury in different phenotypes and disability stages of multiple sclerosis. The results showed that innate immune cell characteristics and myelin loss occurred independently in both white matter and gray matter structures, and were associated with disability.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2022)

Article Clinical Neurology

Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET

Marjo Nylund et al.

Summary: The study used 18 kDa translocator protein-PET imaging to phenotype chronic lesions in multiple sclerosis, finding that secondary progressive patients had a higher proportion of rim-active lesions compared to relapsing-remitting patients, and these lesions were correlated with disability.

BRAIN COMMUNICATIONS (2022)

Review Clinical Neurology

Smouldering multiple sclerosis: the 'real MS'

Gavin Giovannoni et al.

Summary: This article challenges the view that multiple sclerosis is purely an inflammatory disease and proposes a more comprehensive pathological process. It also emphasizes the importance of considering systemic disease processes in the management of multiple sclerosis.

THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS (2022)

Article Clinical Neurology

Perilesional neurodegenerative injury in multiple sclerosis: Relation to focal lesions and impact on disability

Margareta A. Clarke et al.

Summary: The study aimed to assess myelin and axonal damage in the normal appearing white matter of multiple sclerosis patients using advanced MRI techniques. Results showed that focal axonal injury propagation in surrounding tissue correlates with patient disability, emphasizing the importance of preventing chronic black hole development for preserving NAWM integrity. Longitudinal assessment in a larger sample size may further elucidate the impact of this pathology on disease progression.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2021)

Article Clinical Neurology

Iron Rims in Patients With Multiple Sclerosis as Neurodegenerative Marker? A 7-Tesla Magnetic Resonance Study

A. Dal-Bianco et al.

Summary: This study evaluated subcortical atrophy and ventricular enlargement in patients with MS with IRLs using 7T MRI, serum sNfL levels, and neuropsychological performance. The results showed differences between IRL and non-IRL patients in FLAIR lesion counts, MP2Rage lesion volume, information processing speed, and brain structure volumes.

FRONTIERS IN NEUROLOGY (2021)

Article Neurosciences

Activated microglia do not increase 18 kDa translocator protein (TSPO) expression in the multiple sclerosis brain

Erik Nutma et al.

Summary: The expression of TSPO in the human central nervous system may reflect cell density rather than activation status of microglia/macrophages. This has implications for interpreting TSPO PET signals in MS and other CNS diseases, highlighting the limitations of extrapolating TSPO biology from rodents to humans.
Article Clinical Neurology

Chronic White Matter Inflammation and Serum Neurofilament Levels in Multiple Sclerosis

Pietro Maggi et al.

Summary: Chronic white matter inflammation was found to be associated with elevated levels of sNfL and increased disease severity.

NEUROLOGY (2021)

Article Clinical Neurology

Longitudinal change in TSPO PET imaging in progressive multiple sclerosis

Yeona Kang et al.

Summary: The pilot study identified that innate immune activity may increase over time in patients with progressive MS, with a focus on PK11195 uptake in NAWM, cortex, thalamus, and putamen.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)

Article Clinical Neurology

Correlations between macrophage/microglial activation marker sTREM-2 and measures of T-cell activation, neuroaxonal damage and disease severity in multiple sclerosis

Zara A. Ioannides et al.

Summary: In patients with multiple sclerosis (MS), the level of sTREM-2 in the cerebrospinal fluid (CSF) is positively correlated with T cell activation (sCD27), neuroaxonal damage (NfL and pNfH), disability (EDSS), and disease severity (MSSS).

MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL (2021)

Article Clinical Neurology

CHIT1 at Diagnosis Reflects Long-Term Multiple Sclerosis Disease Activity

Emanuela Oldoni et al.

ANNALS OF NEUROLOGY (2020)

Article Clinical Neurology

Serum glial fibrillary acidic protein correlates with multiple sclerosis disease severity

Heidi Hogel et al.

MULTIPLE SCLEROSIS JOURNAL (2020)

Article Clinical Neurology

Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging

Svetlana Bezukladova et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)

Review Clinical Neurology

Neurofilaments: neurobiological foundations for biomarker applications

Arie R. Gafson et al.

Review Medicine, General & Internal

Multiple sclerosis

Alan J. Thompson et al.

LANCET (2018)

Review Clinical Neurology

Neurofilaments as biomarkers in neurological disorders

Michael Khalil et al.

NATURE REVIEWS NEUROLOGY (2018)

Article Clinical Neurology

Microglial activation, white matter tract damage, and disability in MS

Eero Rissanen et al.

NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2018)

Article Clinical Neurology

Serum Neurofilament Light: A Biomarker of Neuronal Damage in Multiple Sclerosis

Giulio Disanto et al.

ANNALS OF NEUROLOGY (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand 11C-PK11195

Eero Rissanen et al.

JOURNAL OF NUCLEAR MEDICINE (2014)

Article Endocrinology & Metabolism

Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies

Maqsood Yaqub et al.

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)

Article Clinical Neurology

Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations

Natalia M. Moll et al.

ANNALS OF NEUROLOGY (2011)

Article Clinical Neurology

Activated Microglia Mediate Axoglial Disruption That Contributes to Axonal Injury in Multiple Sclerosis

Owain W. Howell et al.

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2010)